This spheroid inhibition was not limited to melanoma, as CSPG4-positive breast cancer spheroids also exhibited reduced spheroid growth in the presence of CAR-MαCSPG4 compared to control CAR-MGFP (Supplemental Fig. 7a, b). Here, CSPG4 is linked to melanoma.